Search across episodes, people, companies, and topics — or ask the AI agent for deeper research and structured analysis.

Browse all available podcasts, episodes, and categories. Explore Technology shows and discover new content to follow.

Manage your subscribed podcasts. New episodes are automatically analyzed with AI when published, so you never miss important discussions.

Your AI analysis feed. Every episode you analyze appears here with key insights, summaries, and extracted intelligence.

Browse individuals mentioned across analyzed episodes. See who's being discussed, in what context, and how often.

Track companies and organizations referenced in podcast discussions. Monitor brand mentions and competitive intelligence.

Explore recurring topics and themes extracted from analyzed episodes. Discover what subjects are driving podcast conversations.

Spot emerging trends identified by AI across analyzed episodes. See what's gaining momentum in podcast discussions.

Browse brands and advertisers identified across analyzed episodes. See which companies sponsor which shows and how often.

Revive Pharmacy

Mentioned in 2 analyzed podcast episodes across 2 shows

Mentioned On

Danny Jones Podcast Mind Pump: Raw Fitness Truth

Episode Mentions

Danny Jones Podcast

Danny Jones Podcast · Feb 27, 2026

#374 - Ex-Pharma Insider Exposes the $368 Billion Health Insurance Scam | Brigham Buhler

“Brigham's compounding pharmacy that compounds medications insurance refuses to cover”

Pharmacy Benefit Manager (PBM) Rebate Schemes and Price ManipulationInsurance Company Conflicts of Interest and Vertical IntegrationFDA Regulatory Capture and Revolving Door with Pharma

Mind Pump: Raw Fitness Truth

Mind Pump: Raw Fitness Truth · Feb 26, 2026

2802: The State of the Hormone & Peptide Industry w/ Vita Bella Founder Phil Vella

“Pharmacy that Transcend owed millions of dollars, contributing to its operational collapse”

Peptide pricing transparency and cost structure analysisQuality control and third-party testing in gray-market peptidesGLP-1 monotherapy risks and combination protocol design